ITIL-168 in Advanced Melanoma
Trial details
- Registry ID
- NCT05050006
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| ITIL-168 in Advanced MelanomaNCT05050006 | Instil Bio | Phase 2 | Terminated | 2023-02-27Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |